The PI3K inhibitor GDC-0941 displays promising in vitro and in vivo efficacy for targeted medulloblastoma therapy

Deregulation of the Phosphoinositide 3-kinase (PI3K)/AKT signalling network is a hallmark of oncogenesis. Also medulloblastoma, the most common malignant brain tumor in children, is characterized by high levels of AKT phosphorylation and activated PI3K signalling in medulloblastoma is associated wit...

Descripción completa

Detalles Bibliográficos
Autores principales: Ehrhardt, Michael, Craveiro, Rogerio B., Holst, Martin I., Pietsch, Torsten, Dilloo, Dagmar
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Impact Journals LLC 2014
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4359256/
https://www.ncbi.nlm.nih.gov/pubmed/25596739

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4359256/
https://www.ncbi.nlm.nih.gov/pubmed/25596739

Ejemplares similares